Codexis (CDXS) Tax Rate Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Codexis | 251.43 Mn | 186.29 Mn | 13.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.00 |
| Dec 31, 2025 | 140.00 |
| Sep 30, 2025 | 4.00 |
| Jun 30, 2025 | 419.00 |
| Mar 31, 2025 | 5.00 |
| Dec 31, 2024 | 64.00 |
| Sep 30, 2024 | -472.00 |
| Jun 30, 2024 | 14.00 |
| Mar 31, 2024 | -6.00 |
| Dec 31, 2023 | -28.00 |
| Sep 30, 2023 | 29.00 |
| Jun 30, 2023 | 501.00 |
| Mar 31, 2023 | -1.00 |
| Dec 31, 2022 | -42.00 |
| Sep 30, 2022 | 200.00 |
| Jun 30, 2022 | -402.00 |
| Mar 31, 2022 | -5.00 |
| Dec 31, 2021 | -601.00 |
| Sep 30, 2021 | 472.00 |
| Jun 30, 2021 | -48.00 |
| Mar 31, 2021 | -6.00 |
| Dec 31, 2020 | 535.00 |
| Sep 30, 2020 | 118.00 |
| Jun 30, 2020 | -575.00 |
| Mar 31, 2020 | 26.00 |
| Dec 31, 2019 | -127.00 |
| Jun 30, 2019 | 93.00 |
| Mar 31, 2019 | 10.00 |
| Dec 31, 2018 | -329.00 |
| Sep 30, 2018 | -488.00 |
| Jun 30, 2018 | -713.00 |
| Mar 31, 2018 | 26.00 |
| Dec 31, 2017 | -1,994.00 |
| Sep 30, 2017 | 438.00 |
| Jun 30, 2017 | -424.00 |
| Mar 31, 2017 | -232.00 |
| Dec 31, 2016 | 1.00 |
| Jun 30, 2016 | -127.00 |
| Mar 31, 2016 | -83.00 |
| Dec 31, 2015 | 753.00 |
| Sep 30, 2015 | 1,273.00 |
| Jun 30, 2015 | 884.00 |
| Mar 31, 2015 | 249.00 |
| Dec 31, 2014 | 1,777.00 |
| Sep 30, 2014 | -310.00 |
| Jun 30, 2014 | 173.00 |
| Mar 31, 2014 | 677.00 |
| Dec 31, 2013 | 1,429.00 |
| Sep 30, 2013 | 1,186.00 |
| Jun 30, 2013 | 235.00 |